These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 19166707)

  • 1. Role of platelets in atherothrombosis.
    Jennings LK
    Am J Cardiol; 2009 Feb; 103(3 Suppl):4A-10A. PubMed ID: 19166707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of platelet activation and development of antiplatelet agents].
    Cazenave JP; Gachet C; Lanza F
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
    Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2 receptors, platelet function and pharmacological implications.
    Gachet C
    Thromb Haemost; 2008 Mar; 99(3):466-72. PubMed ID: 18327393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocyte receptors: current views and therapeutic options].
    Peters RJ; Moons AH; Büller HR
    Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1952-7. PubMed ID: 10526614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents.
    Mondoro TH; Vostal JG
    Platelets; 2002 Feb; 13(1):11-20. PubMed ID: 11918832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y12 receptor in platelet activation.
    Kim S; Kunapuli SP
    Platelets; 2011; 22(1):56-60. PubMed ID: 21231822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria.
    Liu CZ; Huang HY; Tsai PJ; Shih MH
    Thromb Res; 2005; 116(2):145-55. PubMed ID: 15907530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
    Langer H; May AE; Bültmann A; Gawaz M
    Thromb Haemost; 2005 Sep; 94(3):555-61. PubMed ID: 16268472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA; Mikhailidis DP
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
    Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
    Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
    Kasirer-Friede A; Legrand C; Frojmovic MM
    Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct but critical roles for integrin alphaIIbbeta3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin.
    Thornber K; McCarty OJ; Watson SP; Pears CJ
    FEBS J; 2006 Nov; 273(22):5032-43. PubMed ID: 17032352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
    Goto S; Tamura N; Ishida H; Ruggeri ZM
    J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets enhance CD4+ lymphocyte adhesion to extracellular matrix under flow conditions: role of platelet aggregation, integrins, and non-integrin receptors.
    Solpov A; Shenkman B; Vitkovsky Y; Brill G; Koltakov A; Farzam N; Varon D; Bank I; Savion N
    Thromb Haemost; 2006 May; 95(5):815-21. PubMed ID: 16676073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.